Table 1.
Studies analyzing the epigenetic effects of different fatty acids concerning inflammatory conditions
Type fatty acid | Dose/concentration | Study model | Epigenetic signatures | Modification types | Inflammation | Reference |
---|---|---|---|---|---|---|
Trans fatty acid elaidate sup | 50 μM | THP-1 monocytes | Global DNA methylation | ↑ | ↑ | [20] |
Saturated fatty acids stearate and palmitate | 200 μM palmitate and 200 μM stearate | Bone marrow–derived macrophages | PPARγ1 promoter DNA methylation | ↑ | ↑ | [21] |
n-6 PUFA | Intake inversely associated | Peripheral white blood cells | TNFα gene promoter methylation | ↓ | ↑ | [22] |
n3-PUFA supplementation | 3 g | Blood leukocyte | Differentially methylated CpG sites related to inflammatory and immune response | ND | ↓ | [24] |
Arachidonic acid | 100 μM | THP-1 cells | Global DNA methylation | ↑ | ↑ | [25] |
n3-PUFA supplementation | EPA and DHA provided in the form of 0.5% Gromega™ | Five sows | On chromosome 4, a 27.7-kb differentially methylated region downstream of RUNX1T1 gene | ↓ | ↓ | [196] |
n3-PUFA supplementation | EPA and DHA provided in the form of 0.5% Gromega™ | Five sows | Intergenic regions of chromosomes 4 and 12 | ↑ | ↓ | [196] |
Oleic acid supplementation | 5 μM | THP-1 cells | Global DNA methylation | ↑ | ↓ | [20] |
Oleic acid supplementation | 100 μM | THP-1 cells | Global DNA methylation | ↓ | ↓ | [25] |
ND non-determined